Alchemy Labs Inc. (TSXV:ALCH)
Canada · Delayed Price · Currency is CAD 0.9800
-0.0200 (-2.00%)
At close: Jul 31, 2026
Alchemy Labs Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 1.91 | 2.27 | 0.14 | 0.62 |
Short-Term Investments | - | 1 | - | - |
Cash & Short-Term Investments | 1.91 | 3.27 | 0.14 | 0.62 |
Cash Growth | 207.57% | 2183.42% | -77.00% | - |
Accounts Receivable | 0.02 | 0.01 | 0.05 | 0.02 |
Other Receivables | 0.16 | - | - | 0.41 |
Receivables | 0.19 | 0.01 | 0.05 | 0.44 |
Inventory | 0.82 | 0.74 | 0.7 | 0.37 |
Prepaid Expenses | - | - | - | 0.01 |
Other Current Assets | 0.46 | 0.53 | 0.3 | - |
Total Current Assets | 3.39 | 4.55 | 1.2 | 1.43 |
Property, Plant & Equipment | 1.81 | 1.75 | 0.18 | 0.14 |
Other Intangible Assets | 0.04 | 0.02 | 0.02 | - |
Long-Term Deferred Charges | 1.82 | 1.63 | 1.07 | 0.63 |
Other Long-Term Assets | 0.07 | 0.09 | 0.06 | - |
Total Assets | 7.13 | 8.04 | 2.54 | 2.2 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accounts Payable | 0.5 | 0.34 | 0.28 | 0.26 |
Accrued Expenses | 0.24 | 0.25 | 0.19 | 0.25 |
Short-Term Debt | 0.04 | 0.04 | 0.02 | - |
Current Portion of Long-Term Debt | 6.42 | 5.89 | 0.07 | 0.08 |
Current Portion of Leases | 0.22 | 0.21 | - | 0.07 |
Current Unearned Revenue | 0.12 | 0.23 | 0.12 | 0.09 |
Other Current Liabilities | 3.47 | 3.36 | 0.4 | 0.06 |
Total Current Liabilities | 11.01 | 10.32 | 1.08 | 0.8 |
Long-Term Debt | 0.68 | 0.58 | 0.37 | 0.21 |
Long-Term Leases | 1.07 | 1.11 | - | - |
Total Liabilities | 12.76 | 12 | 1.44 | 1 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 11.49 | 11.49 | 11.46 | 9.31 |
Additional Paid-In Capital | 1.41 | 1.18 | 0.83 | 0.4 |
Retained Earnings | -18.62 | -16.83 | -11.19 | -8.42 |
Comprehensive Income & Other | 0.09 | 0.19 | -0 | -0.09 |
Shareholders' Equity | -5.63 | -3.97 | 1.1 | 1.2 |
Total Liabilities & Equity | 7.13 | 8.04 | 2.54 | 2.2 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 8.43 | 7.83 | 0.45 | 0.36 |
Net Cash (Debt) | -6.52 | -4.56 | -0.31 | 0.27 |
Net Cash Growth | - | - | - | - |
Net Cash Per Share | -0.23 | -0.16 | -0.01 | 0.01 |
Filing Date Shares Outstanding | 29.02 | 29.02 | 27.81 | 23.27 |
Total Common Shares Outstanding | 27.84 | 27.84 | 27.81 | 23.27 |
Working Capital | -7.62 | -5.77 | 0.13 | 0.64 |
Book Value Per Share | -0.20 | -0.14 | 0.04 | 0.05 |
Tangible Book Value | -5.67 | -3.99 | 1.08 | 1.2 |
Tangible Book Value Per Share | -0.20 | -0.14 | 0.04 | 0.05 |
Machinery | 0.22 | 0.19 | 0.14 | 0.14 |
Construction In Progress | 0.46 | 0.41 | 0.16 | - |
Leasehold Improvements | 0.12 | 0.09 | - | - |